A previous report (Sato et al., 2013) suggested three potential prognostic biomarkers in cerebrospinal fluid for HAM/TSP disease progression: CXCL10, CXCL9, and neopterin. This evidence concerns the gene CXCL10 and tropical spastic paraparesis.